295 related articles for article (PubMed ID: 36535904)
1. Three-tiered EGFr domain risk stratification for individualized NOTCH3-small vessel disease prediction.
Hack RJ; Gravesteijn G; Cerfontaine MN; Santcroos MA; Gatti L; Kopczak A; Bersano A; Duering M; Rutten JW; Lesnik Oberstein SAJ
Brain; 2023 Jul; 146(7):2913-2927. PubMed ID: 36535904
[TBL] [Abstract][Full Text] [Related]
2. Association of
Cerfontaine MN; Hack RJ; Gesierich B; Duering M; Witjes-Ané MW; Rodríguez-Girondo M; Gravesteijn G; Rutten J; Lesnik Oberstein SAJ
Neurology; 2024 May; 102(10):e209310. PubMed ID: 38713890
[TBL] [Abstract][Full Text] [Related]
3. Effect of
Hack RJ; Cerfontaine MN; Gravesteijn G; Tap S; Hafkemeijer A; van der Grond J; Witjes-Ané MN; Baas F; Rutten JW; Lesnik Oberstein SAJ
Stroke; 2022 Oct; 53(10):3133-3144. PubMed ID: 35862191
[TBL] [Abstract][Full Text] [Related]
4. Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy Family Members With a Pathogenic
Hack RJ; Gravesteijn G; Cerfontaine MN; Hegeman IM; Mulder AA; Lesnik Oberstein SAJ; Rutten JW
Stroke; 2022 Jun; 53(6):1964-1974. PubMed ID: 35300531
[TBL] [Abstract][Full Text] [Related]
5. NOTCH3 variant position is associated with NOTCH3 aggregation load in CADASIL vasculature.
Gravesteijn G; Hack RJ; Mulder AA; Cerfontaine MN; van Doorn R; Hegeman IM; Jost CR; Rutten JW; Lesnik Oberstein SAJ
Neuropathol Appl Neurobiol; 2022 Feb; 48(1):e12751. PubMed ID: 34297860
[TBL] [Abstract][Full Text] [Related]
6. Broad phenotype of cysteine-altering
Rutten JW; Hack RJ; Duering M; Gravesteijn G; Dauwerse JG; Overzier M; van den Akker EB; Slagboom E; Holstege H; Nho K; Saykin A; Dichgans M; Malik R; Lesnik Oberstein SAJ
Neurology; 2020 Sep; 95(13):e1835-e1843. PubMed ID: 32732295
[TBL] [Abstract][Full Text] [Related]
7. Association of
Cho BPH; Jolly AA; Nannoni S; Tozer D; Bell S; Markus HS
Neurology; 2022 Aug; 99(5):e430-e439. PubMed ID: 35641310
[TBL] [Abstract][Full Text] [Related]
8. The effect of NOTCH3 pathogenic variant position on CADASIL disease severity: NOTCH3 EGFr 1-6 pathogenic variant are associated with a more severe phenotype and lower survival compared with EGFr 7-34 pathogenic variant.
Rutten JW; Van Eijsden BJ; Duering M; Jouvent E; Opherk C; Pantoni L; Federico A; Dichgans M; Markus HS; Chabriat H; Lesnik Oberstein SAJ
Genet Med; 2019 Mar; 21(3):676-682. PubMed ID: 30032161
[TBL] [Abstract][Full Text] [Related]
9. Cysteine-Altering
Hack RJ; Rutten JW; Person TN; Li J; Khan A; Griessenauer CJ; ; Abedi V; Lesnik Oberstein SAJ; Zand R
Stroke; 2020 Dec; 51(12):3562-3569. PubMed ID: 33161844
[TBL] [Abstract][Full Text] [Related]
10. Distinct phenotypic and functional features of CADASIL mutations in the Notch3 ligand binding domain.
Monet-Leprêtre M; Bardot B; Lemaire B; Domenga V; Godin O; Dichgans M; Tournier-Lasserve E; Cohen-Tannoudji M; Chabriat H; Joutel A
Brain; 2009 Jun; 132(Pt 6):1601-12. PubMed ID: 19293235
[TBL] [Abstract][Full Text] [Related]
11.
Lee YC; Chung CP; Chang MH; Wang SJ; Liao YC
Neurology; 2020 Jan; 94(1):e87-e96. PubMed ID: 31792094
[TBL] [Abstract][Full Text] [Related]
12.
Cho BPH; Nannoni S; Harshfield EL; Tozer D; Gräf S; Bell S; Markus HS
J Neurol Neurosurg Psychiatry; 2021 Jul; 92(7):694-701. PubMed ID: 33712516
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic NOTCH3 cysteine correction in CADASIL using exon skipping: in vitro proof of concept.
Rutten JW; Dauwerse HG; Peters DJ; Goldfarb A; Venselaar H; Haffner C; van Ommen GJ; Aartsma-Rus AM; Lesnik Oberstein SA
Brain; 2016 Apr; 139(Pt 4):1123-35. PubMed ID: 26912635
[TBL] [Abstract][Full Text] [Related]
14. New mutations in the Notch3 gene in patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL).
Abramycheva N; Stepanova M; Kalashnikova L; Zakharova M; Maximova M; Tanashyan M; Lagoda O; Fedotova E; Klyushnikov S; Konovalov R; Sakharova A; Illarioshkin S
J Neurol Sci; 2015 Feb; 349(1-2):196-201. PubMed ID: 25623805
[TBL] [Abstract][Full Text] [Related]
15. Genotype and Phenotype Differences in CADASIL from an Asian Perspective.
Kim Y; Bae JS; Lee JY; Song HK; Lee JH; Lee M; Kim C; Lee SH
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232798
[TBL] [Abstract][Full Text] [Related]
16. Clinical features and spectrum of NOTCH3 variants in Finnish patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL).
Mönkäre S; Kuuluvainen L; Schleutker J; Myllykangas L; Pöyhönen M
Acta Neurol Scand; 2022 Nov; 146(5):643-651. PubMed ID: 36086804
[TBL] [Abstract][Full Text] [Related]
17. A novel cysteine-sparing NOTCH3 mutation in a Chinese family with CADASIL.
Ge W; Kuang H; Wei B; Bo L; Xu Z; Xu X; Geng D; Sun M
PLoS One; 2014; 9(8):e104533. PubMed ID: 25098330
[TBL] [Abstract][Full Text] [Related]
18. A Novel Mutation Outside of the EGFr Encoding Exons of NOTCH3 Gene in a Chinese with CADASIL.
Wang W; Ren Z; Shi Y; Zhang J
J Stroke Cerebrovasc Dis; 2020 Dec; 29(12):105410. PubMed ID: 33254371
[TBL] [Abstract][Full Text] [Related]
19. Genotype-phenotype correlations and effect of mutation location in Japanese CADASIL patients.
Mukai M; Mizuta I; Watanabe-Hosomi A; Koizumi T; Matsuura J; Hamano A; Tomimoto H; Mizuno T
J Hum Genet; 2020 Aug; 65(8):637-646. PubMed ID: 32277177
[TBL] [Abstract][Full Text] [Related]
20. NOTCH3 mutations in a cohort of Portuguese patients within CADASIL spectrum phenotype.
Almeida MR; Elias I; Fernandes C; Machado R; Galego O; Santo G
Neurogenetics; 2022 Jan; 23(1):1-9. PubMed ID: 34851492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
